Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study
Gespeichert in:
Veröffentlicht in: | Blood cancer journal (New York) 2020-06, Vol.10 (6), p.66-66, Article 66 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 66 |
---|---|
container_issue | 6 |
container_start_page | 66 |
container_title | Blood cancer journal (New York) |
container_volume | 10 |
creator | Caocci, Giovanni Mulas, Olga Capodanno, Isabella Abruzzese, Elisabetta Iurlo, Alessandra Luciano, Luigiana Albano, Francesco Annunziata, Mario Tiribelli, Mario Bonifacio, Massimiliano Galimberti, Sara Castagnetti, Fausto Sgherza, Nicola Stagno, Fabio Gozzini, Antonella Orlandi, Ester Maria Luzi, Debora Binotto, Gianni Pregno, Patrizia Fozza, Claudio Efficace, Fabio Simula, Maria Pina Trawinska, Malgorzata Monika Cattaneo, Daniele De Gregorio, Fiorenza Attolico, Immacolata Stella, Rossella Scaffidi, Luigi Baratè, Claudia Gugliotta, Gabriele Scalzulli, Emilia Elena, Chiara Pirillo, Francesca Foà, Robin Breccia, Massimo Nasa, Giorgio La |
description | |
doi_str_mv | 10.1038/s41408-020-0333-2 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7280258</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2411106883</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3852-4b4eb50d512541b97d38fc2ae2dda865144efeb55623495c038ec161378762d93</originalsourceid><addsrcrecordid>eNp1kttu1DAQhiMEolXpA3CDLHFTJFJ8SLLeG6RqOUpB3MC15bUnu26dONjOrvLQvAOzbGkLEr7x6Zt_xuO_KJ4zesmokG9SxSoqS8ppSYUQJX9UnHJaVWUtZP34wfqkOE_pmuKoG7Zky6fFieA1qxijp8XPNuyJD_vSwpBcnol3YxhjyOAGctG-a1-9JmYbPKQMMXiiB0tydBs_G4jOQiKj16nXxMMOfCI6AtEpBeN0Bkv2Lm9JBDsZ3ESXbkjokEEtpz0JxvgpuR0QDB5yIpjTbGMYnCH9DD44i7rTDfROk1Fn9xvKEe61xzDg-eDWh9i8BUymfeldB5fkiqx0P06JrL60JOXJzs-KJ532Cc5v57Pi-4f331afyvbrx8-rq7Y02C9eVusK1jW1NeN1xdbLhRWyM1wDt1bLBntXQYdE3XBRLWuD3wGGNUws5KLhdinOirdH3XFa92AN1h21V2N0vY6zCtqpv28Gt1WbsFMLLimvJQpc3ArE8GPC5qveJQPe6wHClBTH32O0kVIg-vIf9DpMccDnHSjaNI2QC6TYkTIxpBShuyuGUXXwkzr6SaGf1MFPimPMi4evuIv44x4E-BFIeDVsIN6n_r_qL5Hh2qY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2410666387</pqid></control><display><type>article</type><title>Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study</title><source>MEDLINE</source><source>Nature Free</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Springer Nature OA Free Journals</source><creator>Caocci, Giovanni ; Mulas, Olga ; Capodanno, Isabella ; Abruzzese, Elisabetta ; Iurlo, Alessandra ; Luciano, Luigiana ; Albano, Francesco ; Annunziata, Mario ; Tiribelli, Mario ; Bonifacio, Massimiliano ; Galimberti, Sara ; Castagnetti, Fausto ; Sgherza, Nicola ; Stagno, Fabio ; Gozzini, Antonella ; Orlandi, Ester Maria ; Luzi, Debora ; Binotto, Gianni ; Pregno, Patrizia ; Fozza, Claudio ; Efficace, Fabio ; Simula, Maria Pina ; Trawinska, Malgorzata Monika ; Cattaneo, Daniele ; De Gregorio, Fiorenza ; Attolico, Immacolata ; Stella, Rossella ; Scaffidi, Luigi ; Baratè, Claudia ; Gugliotta, Gabriele ; Scalzulli, Emilia ; Elena, Chiara ; Pirillo, Francesca ; Foà, Robin ; Breccia, Massimo ; Nasa, Giorgio La</creator><creatorcontrib>Caocci, Giovanni ; Mulas, Olga ; Capodanno, Isabella ; Abruzzese, Elisabetta ; Iurlo, Alessandra ; Luciano, Luigiana ; Albano, Francesco ; Annunziata, Mario ; Tiribelli, Mario ; Bonifacio, Massimiliano ; Galimberti, Sara ; Castagnetti, Fausto ; Sgherza, Nicola ; Stagno, Fabio ; Gozzini, Antonella ; Orlandi, Ester Maria ; Luzi, Debora ; Binotto, Gianni ; Pregno, Patrizia ; Fozza, Claudio ; Efficace, Fabio ; Simula, Maria Pina ; Trawinska, Malgorzata Monika ; Cattaneo, Daniele ; De Gregorio, Fiorenza ; Attolico, Immacolata ; Stella, Rossella ; Scaffidi, Luigi ; Baratè, Claudia ; Gugliotta, Gabriele ; Scalzulli, Emilia ; Elena, Chiara ; Pirillo, Francesca ; Foà, Robin ; Breccia, Massimo ; Nasa, Giorgio La</creatorcontrib><identifier>ISSN: 2044-5385</identifier><identifier>EISSN: 2044-5385</identifier><identifier>DOI: 10.1038/s41408-020-0333-2</identifier><identifier>PMID: 32514110</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/67/1990/2331 ; 692/499 ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents - therapeutic use ; Arterial Occlusive Diseases - blood ; Arterial Occlusive Diseases - etiology ; Arterial Occlusive Diseases - prevention & control ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Cholesterol - blood ; Female ; Hematology ; Humans ; Imidazoles - therapeutic use ; Inhibitor drugs ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - blood ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy ; Lipoproteins, LDL - blood ; Male ; Middle Aged ; Oncology ; Protective Factors ; Pyridazines - therapeutic use ; Targeted cancer therapy ; Triglycerides - blood ; Young Adult</subject><ispartof>Blood cancer journal (New York), 2020-06, Vol.10 (6), p.66-66, Article 66</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3852-4b4eb50d512541b97d38fc2ae2dda865144efeb55623495c038ec161378762d93</citedby><cites>FETCH-LOGICAL-c3852-4b4eb50d512541b97d38fc2ae2dda865144efeb55623495c038ec161378762d93</cites><orcidid>0000-0001-5447-1068 ; 0000-0002-7947-158X ; 0000-0002-4620-0038 ; 0000-0001-9449-2621 ; 0000-0003-0716-1686 ; 0000-0002-6585-5187 ; 0000-0001-5228-6491 ; 0000-0001-7926-6052 ; 0000-0002-3527-3151</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280258/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280258/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,41096,42165,51551,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32514110$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Caocci, Giovanni</creatorcontrib><creatorcontrib>Mulas, Olga</creatorcontrib><creatorcontrib>Capodanno, Isabella</creatorcontrib><creatorcontrib>Abruzzese, Elisabetta</creatorcontrib><creatorcontrib>Iurlo, Alessandra</creatorcontrib><creatorcontrib>Luciano, Luigiana</creatorcontrib><creatorcontrib>Albano, Francesco</creatorcontrib><creatorcontrib>Annunziata, Mario</creatorcontrib><creatorcontrib>Tiribelli, Mario</creatorcontrib><creatorcontrib>Bonifacio, Massimiliano</creatorcontrib><creatorcontrib>Galimberti, Sara</creatorcontrib><creatorcontrib>Castagnetti, Fausto</creatorcontrib><creatorcontrib>Sgherza, Nicola</creatorcontrib><creatorcontrib>Stagno, Fabio</creatorcontrib><creatorcontrib>Gozzini, Antonella</creatorcontrib><creatorcontrib>Orlandi, Ester Maria</creatorcontrib><creatorcontrib>Luzi, Debora</creatorcontrib><creatorcontrib>Binotto, Gianni</creatorcontrib><creatorcontrib>Pregno, Patrizia</creatorcontrib><creatorcontrib>Fozza, Claudio</creatorcontrib><creatorcontrib>Efficace, Fabio</creatorcontrib><creatorcontrib>Simula, Maria Pina</creatorcontrib><creatorcontrib>Trawinska, Malgorzata Monika</creatorcontrib><creatorcontrib>Cattaneo, Daniele</creatorcontrib><creatorcontrib>De Gregorio, Fiorenza</creatorcontrib><creatorcontrib>Attolico, Immacolata</creatorcontrib><creatorcontrib>Stella, Rossella</creatorcontrib><creatorcontrib>Scaffidi, Luigi</creatorcontrib><creatorcontrib>Baratè, Claudia</creatorcontrib><creatorcontrib>Gugliotta, Gabriele</creatorcontrib><creatorcontrib>Scalzulli, Emilia</creatorcontrib><creatorcontrib>Elena, Chiara</creatorcontrib><creatorcontrib>Pirillo, Francesca</creatorcontrib><creatorcontrib>Foà, Robin</creatorcontrib><creatorcontrib>Breccia, Massimo</creatorcontrib><creatorcontrib>Nasa, Giorgio La</creatorcontrib><title>Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study</title><title>Blood cancer journal (New York)</title><addtitle>Blood Cancer J</addtitle><addtitle>Blood Cancer J</addtitle><subject>631/67/1990/2331</subject><subject>692/499</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Arterial Occlusive Diseases - blood</subject><subject>Arterial Occlusive Diseases - etiology</subject><subject>Arterial Occlusive Diseases - prevention & control</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Cholesterol - blood</subject><subject>Female</subject><subject>Hematology</subject><subject>Humans</subject><subject>Imidazoles - therapeutic use</subject><subject>Inhibitor drugs</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - blood</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</subject><subject>Lipoproteins, LDL - blood</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Oncology</subject><subject>Protective Factors</subject><subject>Pyridazines - therapeutic use</subject><subject>Targeted cancer therapy</subject><subject>Triglycerides - blood</subject><subject>Young Adult</subject><issn>2044-5385</issn><issn>2044-5385</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kttu1DAQhiMEolXpA3CDLHFTJFJ8SLLeG6RqOUpB3MC15bUnu26dONjOrvLQvAOzbGkLEr7x6Zt_xuO_KJ4zesmokG9SxSoqS8ppSYUQJX9UnHJaVWUtZP34wfqkOE_pmuKoG7Zky6fFieA1qxijp8XPNuyJD_vSwpBcnol3YxhjyOAGctG-a1-9JmYbPKQMMXiiB0tydBs_G4jOQiKj16nXxMMOfCI6AtEpBeN0Bkv2Lm9JBDsZ3ESXbkjokEEtpz0JxvgpuR0QDB5yIpjTbGMYnCH9DD44i7rTDfROk1Fn9xvKEe61xzDg-eDWh9i8BUymfeldB5fkiqx0P06JrL60JOXJzs-KJ532Cc5v57Pi-4f331afyvbrx8-rq7Y02C9eVusK1jW1NeN1xdbLhRWyM1wDt1bLBntXQYdE3XBRLWuD3wGGNUws5KLhdinOirdH3XFa92AN1h21V2N0vY6zCtqpv28Gt1WbsFMLLimvJQpc3ArE8GPC5qveJQPe6wHClBTH32O0kVIg-vIf9DpMccDnHSjaNI2QC6TYkTIxpBShuyuGUXXwkzr6SaGf1MFPimPMi4evuIv44x4E-BFIeDVsIN6n_r_qL5Hh2qY</recordid><startdate>20200608</startdate><enddate>20200608</enddate><creator>Caocci, Giovanni</creator><creator>Mulas, Olga</creator><creator>Capodanno, Isabella</creator><creator>Abruzzese, Elisabetta</creator><creator>Iurlo, Alessandra</creator><creator>Luciano, Luigiana</creator><creator>Albano, Francesco</creator><creator>Annunziata, Mario</creator><creator>Tiribelli, Mario</creator><creator>Bonifacio, Massimiliano</creator><creator>Galimberti, Sara</creator><creator>Castagnetti, Fausto</creator><creator>Sgherza, Nicola</creator><creator>Stagno, Fabio</creator><creator>Gozzini, Antonella</creator><creator>Orlandi, Ester Maria</creator><creator>Luzi, Debora</creator><creator>Binotto, Gianni</creator><creator>Pregno, Patrizia</creator><creator>Fozza, Claudio</creator><creator>Efficace, Fabio</creator><creator>Simula, Maria Pina</creator><creator>Trawinska, Malgorzata Monika</creator><creator>Cattaneo, Daniele</creator><creator>De Gregorio, Fiorenza</creator><creator>Attolico, Immacolata</creator><creator>Stella, Rossella</creator><creator>Scaffidi, Luigi</creator><creator>Baratè, Claudia</creator><creator>Gugliotta, Gabriele</creator><creator>Scalzulli, Emilia</creator><creator>Elena, Chiara</creator><creator>Pirillo, Francesca</creator><creator>Foà, Robin</creator><creator>Breccia, Massimo</creator><creator>Nasa, Giorgio La</creator><general>Nature Publishing Group UK</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5447-1068</orcidid><orcidid>https://orcid.org/0000-0002-7947-158X</orcidid><orcidid>https://orcid.org/0000-0002-4620-0038</orcidid><orcidid>https://orcid.org/0000-0001-9449-2621</orcidid><orcidid>https://orcid.org/0000-0003-0716-1686</orcidid><orcidid>https://orcid.org/0000-0002-6585-5187</orcidid><orcidid>https://orcid.org/0000-0001-5228-6491</orcidid><orcidid>https://orcid.org/0000-0001-7926-6052</orcidid><orcidid>https://orcid.org/0000-0002-3527-3151</orcidid></search><sort><creationdate>20200608</creationdate><title>Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study</title><author>Caocci, Giovanni ; Mulas, Olga ; Capodanno, Isabella ; Abruzzese, Elisabetta ; Iurlo, Alessandra ; Luciano, Luigiana ; Albano, Francesco ; Annunziata, Mario ; Tiribelli, Mario ; Bonifacio, Massimiliano ; Galimberti, Sara ; Castagnetti, Fausto ; Sgherza, Nicola ; Stagno, Fabio ; Gozzini, Antonella ; Orlandi, Ester Maria ; Luzi, Debora ; Binotto, Gianni ; Pregno, Patrizia ; Fozza, Claudio ; Efficace, Fabio ; Simula, Maria Pina ; Trawinska, Malgorzata Monika ; Cattaneo, Daniele ; De Gregorio, Fiorenza ; Attolico, Immacolata ; Stella, Rossella ; Scaffidi, Luigi ; Baratè, Claudia ; Gugliotta, Gabriele ; Scalzulli, Emilia ; Elena, Chiara ; Pirillo, Francesca ; Foà, Robin ; Breccia, Massimo ; Nasa, Giorgio La</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3852-4b4eb50d512541b97d38fc2ae2dda865144efeb55623495c038ec161378762d93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>631/67/1990/2331</topic><topic>692/499</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Arterial Occlusive Diseases - blood</topic><topic>Arterial Occlusive Diseases - etiology</topic><topic>Arterial Occlusive Diseases - prevention & control</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Cholesterol - blood</topic><topic>Female</topic><topic>Hematology</topic><topic>Humans</topic><topic>Imidazoles - therapeutic use</topic><topic>Inhibitor drugs</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - blood</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</topic><topic>Lipoproteins, LDL - blood</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Oncology</topic><topic>Protective Factors</topic><topic>Pyridazines - therapeutic use</topic><topic>Targeted cancer therapy</topic><topic>Triglycerides - blood</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Caocci, Giovanni</creatorcontrib><creatorcontrib>Mulas, Olga</creatorcontrib><creatorcontrib>Capodanno, Isabella</creatorcontrib><creatorcontrib>Abruzzese, Elisabetta</creatorcontrib><creatorcontrib>Iurlo, Alessandra</creatorcontrib><creatorcontrib>Luciano, Luigiana</creatorcontrib><creatorcontrib>Albano, Francesco</creatorcontrib><creatorcontrib>Annunziata, Mario</creatorcontrib><creatorcontrib>Tiribelli, Mario</creatorcontrib><creatorcontrib>Bonifacio, Massimiliano</creatorcontrib><creatorcontrib>Galimberti, Sara</creatorcontrib><creatorcontrib>Castagnetti, Fausto</creatorcontrib><creatorcontrib>Sgherza, Nicola</creatorcontrib><creatorcontrib>Stagno, Fabio</creatorcontrib><creatorcontrib>Gozzini, Antonella</creatorcontrib><creatorcontrib>Orlandi, Ester Maria</creatorcontrib><creatorcontrib>Luzi, Debora</creatorcontrib><creatorcontrib>Binotto, Gianni</creatorcontrib><creatorcontrib>Pregno, Patrizia</creatorcontrib><creatorcontrib>Fozza, Claudio</creatorcontrib><creatorcontrib>Efficace, Fabio</creatorcontrib><creatorcontrib>Simula, Maria Pina</creatorcontrib><creatorcontrib>Trawinska, Malgorzata Monika</creatorcontrib><creatorcontrib>Cattaneo, Daniele</creatorcontrib><creatorcontrib>De Gregorio, Fiorenza</creatorcontrib><creatorcontrib>Attolico, Immacolata</creatorcontrib><creatorcontrib>Stella, Rossella</creatorcontrib><creatorcontrib>Scaffidi, Luigi</creatorcontrib><creatorcontrib>Baratè, Claudia</creatorcontrib><creatorcontrib>Gugliotta, Gabriele</creatorcontrib><creatorcontrib>Scalzulli, Emilia</creatorcontrib><creatorcontrib>Elena, Chiara</creatorcontrib><creatorcontrib>Pirillo, Francesca</creatorcontrib><creatorcontrib>Foà, Robin</creatorcontrib><creatorcontrib>Breccia, Massimo</creatorcontrib><creatorcontrib>Nasa, Giorgio La</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Blood cancer journal (New York)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Caocci, Giovanni</au><au>Mulas, Olga</au><au>Capodanno, Isabella</au><au>Abruzzese, Elisabetta</au><au>Iurlo, Alessandra</au><au>Luciano, Luigiana</au><au>Albano, Francesco</au><au>Annunziata, Mario</au><au>Tiribelli, Mario</au><au>Bonifacio, Massimiliano</au><au>Galimberti, Sara</au><au>Castagnetti, Fausto</au><au>Sgherza, Nicola</au><au>Stagno, Fabio</au><au>Gozzini, Antonella</au><au>Orlandi, Ester Maria</au><au>Luzi, Debora</au><au>Binotto, Gianni</au><au>Pregno, Patrizia</au><au>Fozza, Claudio</au><au>Efficace, Fabio</au><au>Simula, Maria Pina</au><au>Trawinska, Malgorzata Monika</au><au>Cattaneo, Daniele</au><au>De Gregorio, Fiorenza</au><au>Attolico, Immacolata</au><au>Stella, Rossella</au><au>Scaffidi, Luigi</au><au>Baratè, Claudia</au><au>Gugliotta, Gabriele</au><au>Scalzulli, Emilia</au><au>Elena, Chiara</au><au>Pirillo, Francesca</au><au>Foà, Robin</au><au>Breccia, Massimo</au><au>Nasa, Giorgio La</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study</atitle><jtitle>Blood cancer journal (New York)</jtitle><stitle>Blood Cancer J</stitle><addtitle>Blood Cancer J</addtitle><date>2020-06-08</date><risdate>2020</risdate><volume>10</volume><issue>6</issue><spage>66</spage><epage>66</epage><pages>66-66</pages><artnum>66</artnum><issn>2044-5385</issn><eissn>2044-5385</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>32514110</pmid><doi>10.1038/s41408-020-0333-2</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-5447-1068</orcidid><orcidid>https://orcid.org/0000-0002-7947-158X</orcidid><orcidid>https://orcid.org/0000-0002-4620-0038</orcidid><orcidid>https://orcid.org/0000-0001-9449-2621</orcidid><orcidid>https://orcid.org/0000-0003-0716-1686</orcidid><orcidid>https://orcid.org/0000-0002-6585-5187</orcidid><orcidid>https://orcid.org/0000-0001-5228-6491</orcidid><orcidid>https://orcid.org/0000-0001-7926-6052</orcidid><orcidid>https://orcid.org/0000-0002-3527-3151</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2044-5385 |
ispartof | Blood cancer journal (New York), 2020-06, Vol.10 (6), p.66-66, Article 66 |
issn | 2044-5385 2044-5385 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7280258 |
source | MEDLINE; Nature Free; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Springer Nature OA Free Journals |
subjects | 631/67/1990/2331 692/499 Adult Aged Aged, 80 and over Antineoplastic Agents - therapeutic use Arterial Occlusive Diseases - blood Arterial Occlusive Diseases - etiology Arterial Occlusive Diseases - prevention & control Biomedical and Life Sciences Biomedicine Cancer Research Cholesterol - blood Female Hematology Humans Imidazoles - therapeutic use Inhibitor drugs Leukemia, Myelogenous, Chronic, BCR-ABL Positive - blood Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Lipoproteins, LDL - blood Male Middle Aged Oncology Protective Factors Pyridazines - therapeutic use Targeted cancer therapy Triglycerides - blood Young Adult |
title | Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T18%3A30%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low%20low-density%20lipoprotein%20(LDL),%20cholesterol%20and%20triglycerides%20plasma%20levels%20are%20associated%20with%20reduced%20risk%20of%20arterial%20occlusive%20events%20in%20chronic%20myeloid%20leukemia%20patients%20treated%20with%20ponatinib%20in%20the%20real-life.%20A%20Campus%20CML%20study&rft.jtitle=Blood%20cancer%20journal%20(New%20York)&rft.au=Caocci,%20Giovanni&rft.date=2020-06-08&rft.volume=10&rft.issue=6&rft.spage=66&rft.epage=66&rft.pages=66-66&rft.artnum=66&rft.issn=2044-5385&rft.eissn=2044-5385&rft_id=info:doi/10.1038/s41408-020-0333-2&rft_dat=%3Cproquest_pubme%3E2411106883%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2410666387&rft_id=info:pmid/32514110&rfr_iscdi=true |